CCCC vs LEN · rev $35.6M vs rev $34.19B
C4 Therapeutics Inc (CCCC) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
LEN (LEN) common stock.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
CCCC currently screens at market cap $425.7M. LEN currently screens at market cap $0.
Not investment advice. Open the CCCC and LEN stock pages for the full models.
Not investment advice.